Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.73245
-0.0111 (-1.49%)
At close: May 15, 2026, 4:00 PM EDT
0.7103
-0.0222 (-3.02%)
Pre-market: May 18, 2026, 4:15 AM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $7.9 million as of May 18, 2026. Its market cap has increased by 13.72% in one year.
Market Cap
7.90M
Enterprise Value
9.32M
1-Year Change
13.72%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.90M, a decrease of -71.80%. That is a compound annual growth rate of -6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 7.90M | -3.86% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 9.07M |
| Genprex | 8.65M |
| PharmaCyte Biotech | 8.64M |
| Curanex Pharmaceuticals | 8.52M |
| CDT Equity | 8.38M |
| Creative Medical Technology Holdings | 8.28M |
| HCW Biologics | 8.22M |
| Liminatus Pharma | 8.08M |